Elanco Animal Health Files Q2 2024 10-Q
Ticker: ELAN · Form: 10-Q · Filed: 2024-08-08T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, animal-health
TL;DR
Elanco's Q2 2024 10-Q is in. Check financials.
AI Summary
Elanco Animal Health Inc. filed its 10-Q for the period ending June 30, 2024. The filing covers the second quarter of 2024, detailing financial performance and business operations. Key financial data and operational updates for the period are presented in this report.
Why It Matters
This filing provides investors with a detailed look at Elanco's financial health and operational performance during the second quarter of 2024, impacting investment decisions.
Risk Assessment
Risk Level: medium — 10-Q filings are standard financial reports, but the specific details within can reveal significant risks or opportunities.
Key Players & Entities
- Elanco Animal Health Inc. (company) — Filer of the 10-Q report.
- June 30, 2024 (date) — End of the reporting period for the 10-Q.
- 20240808 (date) — Filing date of the 10-Q.
- 2024 Q2 (date) — Fiscal quarter covered by the report.
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the quarter ended June 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed on August 8, 2024.
What is the Standard Industrial Classification (SIC) code for Elanco Animal Health Inc.?
The SIC code for Elanco Animal Health Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the company's fiscal year end?
Elanco Animal Health Inc.'s fiscal year ends on December 31.
What is the SEC file number for Elanco Animal Health Inc.?
The SEC file number for Elanco Animal Health Inc. is 001-38661.
From the Filing
0001739104-24-000027.txt : 20240808 0001739104-24-000027.hdr.sgml : 20240808 20240808091002 ACCESSION NUMBER: 0001739104-24-000027 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20240630 FILED AS OF DATE: 20240808 DATE AS OF CHANGE: 20240808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elanco Animal Health Inc CENTRAL INDEX KEY: 0001739104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825497352 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38661 FILM NUMBER: 241186324 BUSINESS ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 BUSINESS PHONE: 877-352-6261 MAIL ADDRESS: STREET 1: 2500 INNOVATION WAY CITY: GREENFIELD STATE: IN ZIP: 46140 10-Q 1 elan-20240630.htm 10-Q FOR THE PERIOD ENDED JUNE 30, 2024 elan-20240630 false 2024 Q2 0001739104 --12-31 1 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure elan:employee elan:reporting_unit iso4217:CHF 0001739104 2024-01-01 2024-06-30 0001739104 2024-08-05 0001739104 2024-04-01 2024-06-30 0001739104 2023-04-01 2023-06-30 0001739104 2023-01-01 2023-06-30 0001739104 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001739104 2024-06-30 0001739104 2023-12-31 0001739104 us-gaap:CommonStockMember 2022-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2022-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-12-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-12-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001739104 2022-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001739104 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-01-01 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001739104 us-gaap:CommonStockMember 2023-03-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001739104 us-gaap:RetainedEarningsMember 2023-03-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-03-31 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-03-31 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0001739104 2023-03-31 0001739104 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-04-01 2023-06-30 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-04-01 2023-06-30 0001739104 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001739104 us-gaap:CommonStockMember 2023-06-30 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001739104 us-gaap:RetainedEarningsMember 2023-06-30 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-06-30 0001739104 us-gaap:AccumulatedTranslationAdjustmentMember 2023-06-30 0001739104 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2023-06-30 0001739104 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001739104 2023-06-30 0001739104 us-gaap:CommonStockMember 2023-12-31 0001739104 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001739104 us-gaap:RetainedEarningsMember 2023-12-31 0001739104 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2023-12-31